Ep. 397 - What the U.S. midterms mean for biopharma
Summary Coming Soon
Our AI is still processing this episode. Summaries typically appear within 24-48 hours of episode release.
Want to be notified when this summary is ready? Subscribe to get weekly digests with AI summaries of all new episodes.
You just read a 3-minute summary of a 25-minute episode.
Get BioCentury This Week summarized like this every Monday — plus up to 2 more podcasts, free.
Pick Your Podcasts — FreeKeep Reading
More from BioCentury This Week
Ep. 396 - China’s first-order innovation
Nov 7 · 29 min
Marketing Against the Grain
From AI Babysitter to AI Leader
Nov 10
More from BioCentury This Week
Ep. 395 - ESMO analysis & Auchincloss proposal
Nov 3 · 33 min
The Bulwark Podcast
Bill Kristol: This Is the Trump Flailing Phase
Nov 9
More from BioCentury This Week
We summarize every new episode. Want them in your inbox?
Ep. 396 - China’s first-order innovation
Ep. 395 - ESMO analysis & Auchincloss proposal
Ep. 394 - Security concerns in U.S., China reshaping biotech
Ep. 393 - China trends; Roche, Merck KGaA deals; Arrowhead & tau
Ep. 392 - Biotech markets: Pause before the storm?
Similar Episodes
Related episodes from other podcasts
Marketing Against the Grain
Nov 10
From AI Babysitter to AI Leader
The Bulwark Podcast
Nov 9
Bill Kristol: This Is the Trump Flailing Phase
The AI Breakdown
Nov 9
Nvidia CEO Admits Affair With Suspected Chinese Spy
The Startup Ideas Podcast
Nov 9
AI Agents are too good at marketing now
What Bitcoin Did
Nov 9
#228 - Rupert Lowe - Is Britain Going Bankrupt?
This podcast is featured in Best Biotech Podcasts (2026) — ranked and reviewed with AI summaries.
You're clearly into BioCentury This Week.
Every Monday, we deliver AI summaries of the latest episodes from BioCentury This Week and 192+ other podcasts. Free for one show.
Start My Monday DigestNo credit card · Unsubscribe anytime